An animal model of adult T-cell leukemia: Humanized mice with HTLV-1-specific immunity

Blood

Volumn 123, Issue 3, 2014, Pages 346-355

  Tezuka, Kenta ^a   Xun, Runze ^a   Tei, Mami ^a   Ueno, Takaharu ^a   Tanaka, Masakazu ^a   Takenouchi, Norihiro ^a   Fujisawa, Jun Ichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CLONE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE STORM; DOWN REGULATION; FEMALE; HEPATOSPLENOMEGALY; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INTRAOSSEOUS DRUG ADMINISTRATION; LEUKEMOGENESIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; ANIMAL; CELL SEPARATION; CYTOLOGY; DISEASE MODEL; FETUS BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NONOBESE DIABETIC MOUSE; SPLEEN; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIGENS, CD; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DISEASE MODELS, ANIMAL; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; MICE, INBRED NOD; PEPTIDES; SPLEEN; STEM CELLS; VIRAL LOAD;

EID: 84893137215     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-06-508861     Document Type: Article

References (50)

1. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78(10): 6476-6480. (Pubitemid 12179735)
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415-7419. (Pubitemid 11131140)
3. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1(8488):1031-1032. (Pubitemid 16102987)
4. Kondo T, Kono H, Miyamoto N, et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer. 1989;43(6): 1061-1064. (Pubitemid 19158038)
5. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L. The HTLV-1 Tax interactome. Retrovirology. 2008; 5:76.
6. Matsuoka M, Jeang KT. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene. 2011;30(12): 1379-1389.
7. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA. 1984;81(8):2534-2537.
8. Shimoyama M, Minato K, Tobinai K, et al. Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemialymphoma. Jpn J Clin Oncol. 1983;13(Suppl 2): 165-187.
9. Okayama A, Tachibana N, Ishihara S, et al. Increased expression of interleukin-2 receptor alpha on peripheral blood mononuclear cells in HTLV-I tax/rex mRNA-positive asymptomatic carriers. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15(1):70-75.
10. Bieberich CJ, King CM, Tinkle BT, Jay G. A transgenic model of transactivation by the Tax protein of HTLV-I. Virology. 1993;196(1):309-318.
11. Feuer G, Zack JA, Harrington WJ Jr, et al. Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood. 1993;82(3): 722-731. (Pubitemid 23221649)
12. Kondo A, Imada K, Hattori T, et al. A model of in vivo cell proliferation of adult T-cell leukemia. Blood. 1993;82(8):2501-2509. (Pubitemid 23304275)
13. Furuta RA, Sugiura K, Kawakita S, Inada T, Ikehara S, Matsuda T, Fujisawa J. Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression. J Virol. 2002;76(6): 2703-2713. (Pubitemid 34184856)
14. Dewan MZ, Terashima K, Taruishi M, et al. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/ gammac(null) mice: suppression by an inhibitor against NF-kappaB. J Virol. 2003;77(9): 5286-5294. (Pubitemid 36460942)
15. Hasegawa H, Sawa H, Lewis MJ, et al. Thymusderived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med. 2006;12(4):466-472.
16. Banerjee P, Tripp A, Lairmore MD, et al. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood. 2010;115(13):2640- 2648.
17. Villaudy J, Wencker M, Gadot N, et al. HTLV-1 propels thymic human T cell development in "human immune system" Rag2-/- gamma c-/- mice. PLoS Pathog. 2011;7(9):e1002231.
18. Satou Y, Yasunaga J, Zhao T, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011;7(2): e1001274.
19. Kazanji M. HTLV type 1 infection in squirrel monkeys (Saimiri sciureus): a promising animal model for HTLV type 1 human infection. AIDS Res Hum Retroviruses. 2000;16(16):1741-1746.
20. Lairmore MD, Silverman L, Ratner L. Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene. 2005;24(39):6005-6015. (Pubitemid 43086118)
21. Watanabe S, Terashima K, Ohta S, et al. Hematopoietic stem cell-engrafted NOD/SCID/ IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood. 2007;109(1):212-218. (Pubitemid 46070123)
22. Yajima M, Imadome K, Nakagawa A, et al. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis. 2008;198(5):673-682.
23. Hasegawa A, Ohashi T, Hanabuchi S, Kato H, Takemura F, Masuda T, Kannagi M. Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response. J Virol. 2003;77(5):2956-2963. (Pubitemid 36228080)
24. Kannagi M, Hasegawa A, Kinpara S, Shimizu Y, Takamori A, Utsunomiya A. Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity. Cancer Sci. 2011; 102(4):670-676.
25. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175-3182. (Pubitemid 35217065)
26. Kushida T, Inaba M, Hisha H, et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood. 2001;97(10):3292-3299.
27. Wang J, Kimura T, Asada R, et al. SCIDrepopulating cell activity of human cord bloodderived CD34- cells assured by intra-bone marrow injection. Blood. 2003;101(8):2924-2931. (Pubitemid 36857976)
28. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981; 294(5843):770-771. (Pubitemid 12174453)
29. Nie C, Sato K, Misawa N, et al. Selective infection of CD41 effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice. Virology. 2009;394(1):64-72.
30. Takamori A, Hasegawa A, Utsunomiya A, et al. Functional impairment of Tax-specific but not cytomegalovirus-specific CD81 T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology. 2011;8:100.
31. Ueno S, Umeki K, Takajo I, et al. Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes. Int J Cancer. 2012;130(10):2318-2326.
32. Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 1997; 57(21):4862-4867. (Pubitemid 27468995)
33. Umeki K, Hisada M, Maloney EM, Hanchard B, Okayama A. Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica. Intervirology. 2009;52(3):115-122.
34. Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura K, Nakahata T. Complete reconstitution of human lymphocytes from cord blood CD341 cells using the NOD/SCID/ gammacnull mice model. Blood. 2003;102(3): 873-880. (Pubitemid 36917778)
35. Nitta T, Tanaka M, Sun B, Hanai S, Miwa M. The genetic background as a determinant of human Tcell leukemia virus type 1 proviral load. Biochem Biophys Res Commun. 2003;309(1):161-165. (Pubitemid 36999772)
36. Yamano Y, Araya N, Sato T, et al. Abnormally high levels of virus-infected IFN-gamma1 CCR41 CD41 CD251 T cells in a retrovirusassociated neuroinflammatory disorder. PLoS ONE. 2009;4(8):e6517.
37. Matsuda M, Maeda Y, Shirakawa C, et al. CD3 down-regulating factor in sera and culture supernatants of leukaemic cells from patients with adult T cell leukaemia. Br J Haematol. 1993;83(2): 212-217. (Pubitemid 23060916)
38. Yamada Y, Ohmoto Y, Hata T, et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma. 1996;21(5-6): 443-447. (Pubitemid 26144768)
39. Chiba K, Hashino S, Izumiyama K, Toyoshima N, Suzuki S, Kurosawa M, Asaka M. Multiple osteolytic bone lesions with high serum levels of interleukin-6 and CCL chemokines in a patient with adult T cell leukemia. Int J Lab Hematol. 2009;31(3):368-371.
40. Chen J, Petrus M, Bryant BR, et al. Autocrine/ paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia. Blood. 2010;116(26):5948-5956.
41. Ohshima K, Mukai Y, Shiraki H, Suzumiya J, Tashiro K, Kikuchi M. Clonal integration and expression of human T-cell lymphotropic virus type I in carriers detected by polymerase chain reaction and inverse PCR. Am J Hematol. 1997; 54(4):306-312. (Pubitemid 27160862)
42. Kurihara K, Harashima N, Hanabuchi S, et al. Potential immunogenicity of adult T cell leukemia cells in vivo. Int J Cancer. 2005;114(2):257-267. (Pubitemid 40194295)
43. Akimoto M, Kozako T, Sawada T, et al. Anti- HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers. J Med Virol. 2007;79(7):977-986. (Pubitemid 46871557)
44. Harashima N, Kurihara K, Utsunomiya A, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64(1):391-399. (Pubitemid 38114123)
45. Kozako T, Arima N, Toji S, et al. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD81 T cell in adult T cell leukemia patients. J Immunol. 2006; 177(8):5718-5726. (Pubitemid 44529666)
46. Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, Kamiyama Y, Ikehara S. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells. 2004; 22(2):125-134. (Pubitemid 38282628)
47. Jaatinen T, Hemmoranta H, Hautaniemi S, et al. Global gene expression profile of human cord blood-derived CD1331 cells. Stem Cells. 2006; 24(3):631-641. (Pubitemid 44464767)
48. Herrera MB, Bruno S, Buttiglieri S, et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells. 2006;24(12): 2840-2850. (Pubitemid 46053020)
49. Martin-Rendon E, Hale SJ, Ryan D, et al. Transcriptional profiling of human cord blood CD1331 and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells. 2007;25(4):1003-1012. (Pubitemid 46572598)
50. Kuruvilla JG, Troyer RM, Devi S, Akkina R. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology. 2007;369(1):143-152. (Pubitemid 350029864) Technology Technology